VTRS - Viatris Q3 2023 Earnings Preview
2023-11-06 12:59:29 ET
More on Viatris
- Viatris: Get Paid 5%, Before Growth Materializes
- Viatris' Survival Guide: Strategic Divestitures And Margins
- Viatris: Generic Semaglutide Could Become The Poor Man's Option For Weight Loss
- Theravance, Mylan settle patent litigation over COPD drug Yupelri
- Viatris downgraded at BofA citing business transition
For further details see:
Viatris Q3 2023 Earnings Preview